Jarosław Gorący
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jarosław Gorący has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
Zdzisława Kornacewicz-Jach
Department od Cardiology, Pomeranian University of Medicine 72 Powstańców Wielkopolskich street, 70-111 Szczecin, Poland
11 shared publicationsMaciej Lewandowski
Department od Cardiology, Pomeranian University of Medicine 72 Powstańców Wielkopolskich street, 70-111 Szczecin, Poland
8 shared publications- Andrzej Ciechanowicz
Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland
7 shared publications - Krzysztof Safranow
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-204 Szczecin, Poland
6 shared publications - Mariusz Kaczmarczyk
Department of Biochemical Science, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland
6 shared publications Andrzej Wojtarowicz
Department of Cardiology, Pomeranian Medical University, Szczecin, Poland
5 shared publications
Latest Publications
- Open Access
- 4 July 2022
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 29 (4) , 540-552
Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
- 4 July 2022
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 29 (4) , 540-552
Open AccessPre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
- Open Access
- 14 March 2019
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 26 (1) , 1-7
Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society
- 14 March 2019
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 26 (1) , 1-7
Open AccessBivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society
- Open Access
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 15 (5) , 1223-1231
E-selectin gene haplotypes are associated with the risk of myocardial infarction
Introduction Endothelial dysfunction is one of the most important factors implicated in the pathogenesis of coronary artery disease (CAD). The aim of this study was to investigate the association of the E-selectin gene (SELE) with CAD and CAD-related traits using tagging polymorphisms....
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 15 (5) , 1223-1231
Open AccessE-selectin gene haplotypes are associated with the risk of myocardial infarction
Introduction Endothelial dysfunction is one of the most important factors implicated in the pathogenesis of coronary artery disease (CAD). The aim of this study was to investigate the association of the E-selectin gene (SELE) with CAD and CAD-related traits using tagging polymorphisms....
- Open Access
- 28 June 2018
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 25 (3) , 291-300
Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint
A group of Polish experts in cardiology and emergency medicine, encouraged by the European Society of Cardiology (ESC) guidelines, have recently published common recommendations for medical emergency teams regarding the pre-hospital management of patients with acute coronary syndrome. Due to the recent publication of the 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation and 2017 focused update on dual antiplatelet therapy in coronary artery disease the current panel of experts decided to update the previous standpoint. Moreover, new data coming from studies presented after the previous document was issued were also taken into consideration. A group of Polish experts in cardiology and emergency medicine, encouraged by the European Society of Cardiology (ESC) guidelines, have recently published common recommendations for medical emergency teams regarding the pre-hospital management of patients with acute coronary syndrome. Due to the recent publication of the 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation and 2017 focused update on dual antiplatelet therapy in coronary artery disease the current panel of experts decided to update the previous standpoint. Moreover, new data coming from studies presented after the previous document was issued were also taken into consideration.
- 28 June 2018
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 25 (3) , 291-300
Open AccessTreatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint
A group of Polish experts in cardiology and emergency medicine, encouraged by the European Society of Cardiology (ESC) guidelines, have recently published common recommendations for medical emergency teams regarding the pre-hospital management of patients with acute coronary syndrome. Due to the recent publication of the 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation and 2017 focused update on dual antiplatelet therapy in coronary artery disease the current panel of experts decided to update the previous standpoint. Moreover, new data coming from studies presented after the previous document was issued were also taken into consideration. A group of Polish experts in cardiology and emergency medicine, encouraged by the European Society of Cardiology (ESC) guidelines, have recently published common recommendations for medical emergency teams regarding the pre-hospital management of patients with acute coronary syndrome. Due to the recent publication of the 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation and 2017 focused update on dual antiplatelet therapy in coronary artery disease the current panel of experts decided to update the previous standpoint. Moreover, new data coming from studies presented after the previous document was issued were also taken into consideration.
- 10 April 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (4) , 813
Vasculitis or coronary atherosclerosis? Optical coherence tomography images in polyarteritis nodosa
- 10 April 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (4) , 813
Vasculitis or coronary atherosclerosis? Optical coherence tomography images in polyarteritis nodosa
- 16 March 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (3) , 662-668
Angiographic severity of coronary artery disease and cardiovascular risk in acute coronary syndrome in patients with metabolic syndrome
Background: Extent of angiographic lesions, size of infarct and in-hospital and distant prognosis in patients with the metabolic syndrome have been not clearly determined. Detailed knowledge of markers both for ACS occurrence as well as those affecting early and further prognosis will have key significance at taking correct preventive and therapeutic decisions. Aim: Comparing in patients with first ACS treated with coronary angioplasty the advancement of coronary disease and the cardiovascular risk evaluated using GRACE 2.0 risk score and the size of the left ventricular ejection fraction depending on co-occurrence of metabolic syndrome Methods: The research was conducted in the group of 160 subsequent patients of the Cardiology Clinic of PUM, hospitalized due to their first in life ACS, treated using the coronary angioplasty, being at the age of 18-70 years. . For all patients the coronarography, that is performed as a routine before angioplasty, was assessed. Before checking out of the hospital the echocardiographic test of the left ventricle function was performed. In all patients the metabolic syndrome was evaluated according to NCEP ATP III criteria. In blood samples taken from the patients the following was marked using routine methods: heart necrosis markers, creatinine concentration ionogram, lipid profile, glucose and insulin concentration, and homeostatic model was calculated. On the basis of acquired data, for all patients the cardiovascular risk was evaluated according to GRACE 2.0 score, using a computer calculator available in the GRACE 2.0 Internet site (www.gracescore.org). Statistical analysis of obtained results was performed using the STATISTICA software varsion 12.0 from StatSoft Inc. Results: Metabolic syndrome criteria were met by 53.5% of examined patients. The examined patients, regardless occurrence of metabolic syndrome, were not different in angiographic advancements of coronary disease and cardiovascular risk as evaluated with the GRACE 2.0 score. In patients with the metabolic syndrome a significantly higher left ventricular ejection fraction was found, compared to patients without this syndrome. In the whole examined group evaluated as a whole, the coronary disease angiographic advancement expressed as the epicardial artery affected correlated alternately positively correlated alternatively positively with age, BMI, insulin and HOMA-IR concentration. The cardiovascular risk assessed with the GRACE 2.0 score correlated with age, BMI, insulin concentration on fasting and with HOMA-IR, and negatively with systolic pressure, diastolic pressure and triglycerides concentration. The multiple regression model for predicting the left ventricular ejection fraction value indicated the strongest prognostic factor for LFEF was the type of acute coronary syndrome. Among other examined parameters, independent and statistically significant effect on the left ventricular ejection fraction had pulse value, Killip class, HDL cholesterol concentration, genetic predisposition toward cardiovascular diseases and the presence of metabolic syndrome. Conclusions: Observed correlative dependence between the coronary disease angiographic advancement and the age, BMI, insulin resistance confirm importance of these parameters in development of the coronary atherosclerosis. Demonstrated correlations between estimated cardiovascular risk, measured using GRACE score and insulin resistance confirm prognostic importance of metabolic parameters in patients after their first ACS. In patients with the first ACS for predicting the discharge fraction of the left ventricle, the most useful is the type of acute coronary syndrome, and among other evaluated parameters the presence of the metabolic syndrome and the pulse value, Killip class, HDL cholesterol concentration and genetic predisposition toward cardiovascular diseases. Background: Extent of angiographic lesions, size of infarct and in-hospital and distant prognosis in patients with the metabolic syndrome have been not clearly determined. Detailed knowledge of markers both for ACS occurrence as well as those affecting early and further prognosis will have key significance at taking correct preventive and therapeutic decisions. Aim: Comparing in patients with first ACS treated with coronary angioplasty the advancement of coronary disease and the cardiovascular risk evaluated using GRACE 2.0 risk score and the size of the left ventricular ejection fraction depending on co-occurrence of metabolic syndrome Methods: The research was conducted in the group of 160 subsequent patients of the Cardiology Clinic of PUM, hospitalized due to their first in life ACS, treated using the coronary angioplasty, being at the age of 18-70 years. . For all patients the coronarography, that is performed as a routine before angioplasty, was assessed. Before checking out of the hospital the echocardiographic test of the left ventricle function was performed. In all patients the metabolic syndrome was evaluated according to NCEP ATP III criteria. In blood samples taken from the patients the following was marked using routine methods: heart necrosis markers, creatinine concentration ionogram, lipid profile, glucose and insulin concentration, and homeostatic model was calculated. On the basis of acquired data, for all patients the cardiovascular risk was evaluated according to GRACE 2.0 score, using a computer calculator available in the GRACE 2.0 Internet site (www.gracescore.org). Statistical analysis of obtained results was performed using the STATISTICA software varsion 12.0 from StatSoft Inc. Results: Metabolic syndrome criteria were met by 53.5% of examined patients. The examined patients, regardless occurrence of metabolic syndrome, were not different in angiographic advancements of coronary disease and cardiovascular risk as evaluated with the GRACE 2.0 score. In patients with the metabolic syndrome a significantly higher left ventricular ejection fraction...
- 16 March 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (3) , 662-668
Angiographic severity of coronary artery disease and cardiovascular risk in acute coronary syndrome in patients with metabolic syndrome
Background: Extent of angiographic lesions, size of infarct and in-hospital and distant prognosis in patients with the metabolic syndrome have been not clearly determined. Detailed knowledge of markers both for ACS occurrence as well as those affecting early and further prognosis will have key significance at taking correct preventive and therapeutic decisions. Aim: Comparing in patients with first ACS treated with coronary angioplasty the advancement of coronary disease and the cardiovascular risk evaluated using GRACE 2.0 risk score and the size of the left ventricular ejection fraction depending on co-occurrence of metabolic syndrome Methods: The research was conducted in the group of 160 subsequent patients of the Cardiology Clinic of PUM, hospitalized due to their first in life ACS, treated using the coronary angioplasty, being at the age of 18-70 years. . For all patients the coronarography, that is performed as a routine before angioplasty, was assessed. Before checking out of the hospital the echocardiographic test of the left ventricle function was performed. In all patients the metabolic syndrome was evaluated according to NCEP ATP III criteria. In blood samples taken from the patients the following was marked using routine methods: heart necrosis markers, creatinine concentration ionogram, lipid profile, glucose and insulin concentration, and homeostatic model was calculated. On the basis of acquired data, for all patients the cardiovascular risk was evaluated according to GRACE 2.0 score, using a computer calculator available in the GRACE 2.0 Internet site (www.gracescore.org). Statistical analysis of obtained results was performed using the STATISTICA software varsion 12.0 from StatSoft Inc. Results: Metabolic syndrome criteria were met by 53.5% of examined patients. The examined patients, regardless occurrence of metabolic syndrome, were not different in angiographic advancements of coronary disease and cardiovascular risk as evaluated with the GRACE 2.0 score. In patients with the metabolic syndrome a significantly higher left ventricular ejection fraction was found, compared to patients without this syndrome. In the whole examined group evaluated as a whole, the coronary disease angiographic advancement expressed as the epicardial artery affected correlated alternately positively correlated alternatively positively with age, BMI, insulin and HOMA-IR concentration. The cardiovascular risk assessed with the GRACE 2.0 score correlated with age, BMI, insulin concentration on fasting and with HOMA-IR, and negatively with systolic pressure, diastolic pressure and triglycerides concentration. The multiple regression model for predicting the left ventricular ejection fraction value indicated the strongest prognostic factor for LFEF was the type of acute coronary syndrome. Among other examined parameters, independent and statistically significant effect on the left ventricular ejection fraction had pulse value, Killip class, HDL cholesterol concentration, genetic predisposition toward cardiovascular diseases and the presence of metabolic syndrome. Conclusions: Observed correlative dependence between the coronary disease angiographic advancement and the age, BMI, insulin resistance confirm importance of these parameters in development of the coronary atherosclerosis. Demonstrated correlations between estimated cardiovascular risk, measured using GRACE score and insulin resistance confirm prognostic importance of metabolic parameters in patients after their first ACS. In patients with the first ACS for predicting the discharge fraction of the left ventricle, the most useful is the type of acute coronary syndrome, and among other evaluated parameters the presence of the metabolic syndrome and the pulse value, Killip class, HDL cholesterol concentration and genetic predisposition toward cardiovascular diseases. Background: Extent of angiographic lesions, size of infarct and in-hospital and distant prognosis in patients with the metabolic syndrome have been not clearly determined. Detailed knowledge of markers both for ACS occurrence as well as those affecting early and further prognosis will have key significance at taking correct preventive and therapeutic decisions. Aim: Comparing in patients with first ACS treated with coronary angioplasty the advancement of coronary disease and the cardiovascular risk evaluated using GRACE 2.0 risk score and the size of the left ventricular ejection fraction depending on co-occurrence of metabolic syndrome Methods: The research was conducted in the group of 160 subsequent patients of the Cardiology Clinic of PUM, hospitalized due to their first in life ACS, treated using the coronary angioplasty, being at the age of 18-70 years. . For all patients the coronarography, that is performed as a routine before angioplasty, was assessed. Before checking out of the hospital the echocardiographic test of the left ventricle function was performed. In all patients the metabolic syndrome was evaluated according to NCEP ATP III criteria. In blood samples taken from the patients the following was marked using routine methods: heart necrosis markers, creatinine concentration ionogram, lipid profile, glucose and insulin concentration, and homeostatic model was calculated. On the basis of acquired data, for all patients the cardiovascular risk was evaluated according to GRACE 2.0 score, using a computer calculator available in the GRACE 2.0 Internet site (www.gracescore.org). Statistical analysis of obtained results was performed using the STATISTICA software varsion 12.0 from StatSoft Inc. Results: Metabolic syndrome criteria were met by 53.5% of examined patients. The examined patients, regardless occurrence of metabolic syndrome, were not different in angiographic advancements of coronary disease and cardiovascular risk as evaluated with the GRACE 2.0 score. In patients with the metabolic syndrome a significantly higher left ventricular ejection fraction...
- 15 September 2017
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 75 (V) , 47-56
Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint
- 15 September 2017
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 75 (V) , 47-56
Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint
- 6 June 2017
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 73 (9) , 1085-1094
Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention
Antiplatelet response to clopidogrel and its influence upon the risk of cardiovascular adverse events among patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI) has not been investigated fully.
- 6 June 2017
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 73 (9) , 1085-1094
Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention
Antiplatelet response to clopidogrel and its influence upon the risk of cardiovascular adverse events among patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI) has not been investigated fully.
- 21 April 2017
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 22 (5)
Scuba diving, patent foramen ovale and heart rhythm disturbances: The role of underwater Holter monitoring—Case report
Patent foramen ovale (PFO) is thought to be a risk factor for decompression illness (DCI). Catheter‐based closure procedure reduces the risk of DCI in selected scuba divers with PFO. Major complication of invasive approach are rare, minor, especially heart rhythm disturbances are reported relatively often. We describe a case of 41‐year‐old diver, who underwent PFO closure due to recurrent DCI events. Afterward, he experienced no DCI symptoms; however, he complained about feeling of the heart beating during a submersion. Arrhythmia should be considered as a life‐threatening for scuba diver, thus we performed underwater ECG monitoring and exclude the arrhythmia.
- 21 April 2017
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 22 (5)
Scuba diving, patent foramen ovale and heart rhythm disturbances: The role of underwater Holter monitoring—Case report
Patent foramen ovale (PFO) is thought to be a risk factor for decompression illness (DCI). Catheter‐based closure procedure reduces the risk of DCI in selected scuba divers with PFO. Major complication of invasive approach are rare, minor, especially heart rhythm disturbances are reported relatively often. We describe a case of 41‐year‐old diver, who underwent PFO closure due to recurrent DCI events. Afterward, he experienced no DCI symptoms; however, he complained about feeling of the heart beating during a submersion. Arrhythmia should be considered as a life‐threatening for scuba diver, thus we performed underwater ECG monitoring and exclude the arrhythmia.
- Open Access
- 14 April 2017
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 75 (4) , 399-408
Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint
- 14 April 2017
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 75 (4) , 399-408
Open AccessAnti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint